Human Fc␥ receptor (Fc␥R) genes form a clustered gene family on chromosome 1q21-24. Although the association of Fc␥R polymorphisms with systemic lupus erythematosus (SLE) has been extensively studied, the results are often contradictory. In this study, Fc␥RIIA-131H/R, Fc␥RIIIA-176F/V and Fc␥RIIIB-NA1/2 genotypes were determined in the Japanese patients with SLE (n = 81) or rheumatoid arthritis (RA, n = 115) as well as in healthy individuals (n = 217), and possible association with the disease was tested using case-control analysis. Unlike in other populations, significant difference was not observed in the frequencies of Fc␥RIIA and Fc␥RIIIA genotypes between patients with SLE and healthy individuals. However, significant difference was detected in the frequencies of Fc␥RIIIB genotypes between SLE and healthy individuals (P = 0.008). The odds ratio [OR] of the Fc␥RIIIB-NA2/NA2 homozygotes for the development of SLE was 2.52 (95% confidence interval [CI]: 1.33-4.79). Among the patients with SLE, individuals with NA2/2 were significantly more likely to have lupus nephritis (P = 0.007). No association was observed between any of the Fc␥R polymorphisms and RA. Significant linkage disequilibrium was detected between Fc␥RIIIA and IIIB, but neither between IIA and IIIA, nor between IIA and IIIB. These observations may underscore the relevance of defective immune complex handling in the pathogenesis of SLE, or may suggest the presence of primarily associated gene(s) in linkage disequilibrium with Fc␥R genes.
Introduction
Receptors for the Fc fragment of IgG (Fc␥Rs) play a unique role of coupling the humoral and cellular immune responses by targeting immune complexes (ICs) to effector cells. 1 Multiple Fc␥Rs, which differ in ligand affinity, cellular distribution, and effector function, constitute a clustered gene family on the long arm of chromosome 1 (1q21-24) in humans. 2, 3 There are three families of Fc␥R (Fc␥RI, Fc␥RII, and Fc␥RIII), each containing multiple distinct genes and alternative splicing variants. 2, 4 Genetic polymorphisms have been found for Fc␥RIIA, Fc␥RIIIA and Fc␥RIIIB which profoundly influence the affinity of the receptor for IgG or phagocytotic capacity. [5] [6] [7] Fc␥RIIA is a low affinity receptor for IgG expressed on macrophages, neutrophils, monocytes and platelets. A single nucleotide polymorphism is present in Fc␥RIIA exon 4, which leads to an amino acid substitution from histidine (H) to arginine (R) at position 131 in the second extracellular domain. 8 Fc␥RIIA-H131 is the only human Fc␥R that efficiently binds IgG2, whereas Fc␥RIIA-R131 binds IgG2 only weakly. 9, 10 Fc␥RIII exists in two alternative membrane forms, which result from cell type specific expression of the two genes. 5 The transmembrane anchored Fc␥RIIIA is expressed on natural killer cells and macrophages. Fc␥RIIIB molecule expressed in neutrophils, in contrast, is anchored by a phosphatidylinositol linkage. 11 Fc␥RIIIA and Fc␥RIIIB bind human IgG1 or IgG3, and to a lesser extent human IgG2. 2 A dimorphism was recently reported at amino acid position 176 (F/V) of Fc␥RIIIA. Fc␥RIIIA-V176 was shown to have higher affinity to IgG1 and IgG3, compared with Fc␥RIIIA-F176. 12 In the case of Fc␥RIIIB, serologically defined two alleles, NA1/NA2, are present which reflect differences in four amino acid positions including two potential glycosylation sites. 13 Homozygous NA2 individuals have lower capacity to mediate phagocytosis compared with individuals who possess NA1. 13 Based on the presence of functionally relevant polymorphisms, Fc␥Rs have been considered as attractive candidates for the susceptibility genes to systemic lupus 15, 16 while no association was found in AfroCaribbean, Chinese, British and Greek Caucasians. 17, 18 The latter studies may lack the statistical power and the results could represent false negatives. A recent study reported that Fc␥RIIA-131H/R polymorphism was associated with clinical symptoms, rather than the development, of SLE. 19 In Korean patients, a lower Fc␥RIIA-H131 allele frequency was observed, particularly in the group of patients with nephritis. 20 As for Fc␥RIIIA, possible association between the presence or homozygosity of Fc␥RIIIA-176F allele and SLE has been reported. [21] [22] [23] (Different nomenclature was used in different studies. In some of them, the first amino acid of the signal sequence was designated as number 1, and the polymorphic site as number 176. 21 In others, the first amino acid of the extracellular domain was designated as number 1, then the polymorphic site was position 158. 12, 22 In the present study, the former nomenclature is used.) The relevance of chromosomal region 1q23 has also been demonstrated by the genome-wide linkage screening. 24, 25 In the complex diseases, studies on different populations with different genetic backgrounds sometimes reveal important information for the identification of the primarily associated genes. Thus far, no studies have been reported concerning the possible association of Fc␥R polymorphisms with SLE in Japanese. The purpose of this study was to obtain information on the polymorphisms of Fc␥RIIA, Fc␥RIIIA and Fc␥RIIIB in Japanese patients with SLE and healthy individuals, and to gain further insight into the role of Fc␥R genes in the development of SLE.
It has been hypothesized that the allelic differences of Fc␥Rs would lead to the defective handling of ICs. Elevated level of ICs was also reported in rheumatoid arthritis (RA), and is suspected to play a role in the pathogenesis. 26 However, the Fc␥R genotypes of patients with RA have not been reported. In this study, we also examined the Fc␥R genotypes of the patients with RA, and tested their possible association with RA.
Results
Comparison of Fc␥RIIA, IIIA and IIIB genotypes among patients with SLE, RA and healthy individuals Fc␥RIIA, IIIA and IIIB genotypes of 81 patients with SLE, 115 patients with RA and 217 healthy individuals were determined. Each genotyping was performed using one or two of the following methods: PCR-restriction fragment length polymorphism (RFLP) with a mismatched primer, PCR-sequence specific primers (SSP), PCR-single strand conformation polymorphisms (SSCP), and PCRpreferential homoduplex formation assay (PHFA). Figure 1 shows the representative RFLP pattern of Fc␥RIIA and SSCP pattern of Fc␥RIIIA genotyping. The genotype frequencies of patients and controls are demonstrated in Table 1 . The frequencies of Fc␥RIIA and IIIB genotypes in healthy Japanese individuals were similar to those recently reported using serological typing. 27 The frequencies of all genotypes were found to be not signifi- Fc␥RIIA-131H/R polymorphism using PCR-RFLP with a mismatched primer. After the second PCR reaction, the amplified products were digested with Nde I for 3 h and analyzed on a 10% polyacrylamide gel with SYBER Gold staining. M: marker (X-174 Hae III). (b) Genotyping of Fc␥RIIIA-176F/V polymorphism using PCR-SSCP. Electrophoresis was carried out using 10% polyacrylamide gels containing 5% glycerol at 4°C for 90 min. The separated fragments were then visualized with silver staining.
cantly different from those predicted from Hardy-Weinberg equilibrium in the healthy individuals and also in the patients, using 2 analysis. In contrast to the previous reports which demonstrated significant associations with Fc␥RIIA or Fc␥RIIIA in other populations, no significant skewing in the genotype frequencies or allele positivities of Fc␥RIIA and Fc␥RIIIA was observed in Japanese patients with SLE (allele positivity was defined as the proportion of the subjects who possess at least one allele). Power calculation revealed that if the number of the patients with SLE had been 5.2-fold higher (n = 422) and the allele frequencies remained the same, the frequency of the Fc␥RIIIA-176F allele would have been significantly higher in SLE compared with the controls. However, to our surprise, significant difference was present in the Fc␥RIIIB genotypes between the patients with SLE and healthy individuals. The genotype NA2/NA2 was significantly overrepresented in SLE, as compared with healthy individuals (P = 0.008, 2 -analysis from 3 × 2 contingency Because of the difference in the sex distribution between the patient and control groups, statistical comparisons were also made using only female patients and controls. The results were essentially identical ( Table 2) . 
Clinical characteristics among patients with different Fc␥Rs genotypes
To determine whether each genotype of Fc␥Rs is a risk factor for the development of nephritis or other clinical characteristics of SLE, 81 SLE patients were analyzed with respect to the genotypes of Fc␥RIIA, IIIA or IIIB (Table 3) . When patients with SLE were divided into two subgroups according to the presence (n = 53) or absence (n = 28) of lupus nephritis, NA2 homozygotes were significantly more likely to have nephritis (17/18, 94.4%). Genotype frequencies of Fc␥RIIA-131H/R and Fc␥RIIIA-176F/V were not different in the patients with or without nephritis. On the other hand, involvement of central nervous system was significantly infrequent in NA2 homozygous patients (1/18, 5.5%). It was also observed that a significantly smaller proportion of Fc␥RIIIA-176V homozygotes had anti-dsDNA antibody (1/4, 25%). However, since the number of 176V homozygotes was small, this association needs further confirmation.
HLA-DRB1*1501 is an established risk factor for SLE in Japanese. 28 No significant difference was present in the HLA-DRB1*1501 positivity among different Fc␥R genotypes, suggesting that no multiplicative effect is present between HLA-DRB1 and Fc␥R alleles (Table 3) . Similarly, multiplicative effect was not observed between Fc␥Rs and TNFR2-196R allele, which was recently found to be associated with SLE by our group 29 (data not shown).
Linkage disequilibrium
Although Fc␥RIIA, IIIA and IIIB constitute a clustered gene family on the long arm of chromosome 1 (1q23-24) in humans, physical distances and allelic associations among them have not been clearly demonstrated. In order to obtain some information on their genetic distances, the allelic associations were analyzed based on the genotyping results of Fc␥RIIA, IIIA and IIIB. Table 4 shows the two-locus Fc␥Rs haplotypes in Japanese healthy individuals. Significant linkage disequilibrium was detected between Fc␥RIIIA and Fc␥RIIIB loci, but neither between Fc␥RIIA and Fc␥RIIIA nor between Fc␥RIIA and Fc␥RIIIB.
Genotype combination
Although the Fc␥R gene shown to be significantly associated with SLE in the previous studies is different among populations, alleles associated with SLE uniformly have weaker binding affinity or lower phagocytotic capacity than the non-associated alleles. One possible interpretation for these observations is that these three Fc␥R genes have similar contributions on conferring the susceptibility to SLE, and the total number of the 'weak-affinity' alleles such as Fc␥RIIA-131R, Fc␥RIIIA-176F and Fc␥RIIIB-NA2 is primarily associated with the susceptibility. This possibility seemed plausible especially considering that heterotypic cross-linking of Fc␥RIIA and IIIB on neutrophils was shown to induce synergistic Ca 2+ response. 30 In order to examine this possibility, frequencies of the Fc␥RIIA and Fc␥RIIIA genotypes were compared between patients with SLE and healthy individuals after they were stratified by the genotype of Fc␥RIIIB. Table 5 demonstrates the results from the comparisons focused only on the female patients and controls. Although a small increase was observed in the proportion of Fc␥RIIIA-176F/F genotype and Fc␥RIIA-131R allele positivity in Fc␥RIIIB-NA1/2 heterozygous patients compared with healthy individuals, the difference did not reach statistical significance. The same tendency was observed when comparisons were made between total patients and healthy individuals (data not shown). These results suggested that primary involvement of Fc␥RIIIB seems to be more likely; however, because of the rather small sample size, the possibility of the cumulative effect could not entirely be excluded.
Discussion
Human Fc␥R molecules coded by different alleles have functionally distinct capacities that are important in mediating interactions between human phagocytes and IgG ligands. Impaired handling and removal of IC by the mononuclear phagocyte system, causing deposition of IC and inflammatory processes in organs and tissues, is considered to be involved in the pathogenesis of SLE. 1, 31, 32 In the present study, the frequencies of Fc␥RIIA-131H/R, Fc␥RIIIA-176F/V and Fc␥RIIIB-NA1/2 polymorphisms in Japanese patients with SLE were compared with ethnically matched healthy individuals. Unlike in other populations, no significant difference was observed between Fc␥RIIA-131H/R, Fc␥RIIIA-176F/V polymorphisms and susceptibility to SLE or lupus nephritis in Japanese. Surprisingly, a significant association was observed between Fc␥RIIIB-NA1/2 polymorphism and SLE. Most of the differences remained significant even after the correction for the multiple testing (data not shown). In addition, among the patients with SLE, those heterozygous for NA2 were significantly more likely to have lupus nephritis.
The diallelic NA1/2 polymorphism of Fc␥RIIIB, expressed only on polymorphonuclear cells, is related to four amino acid differences, two of which alter potential N-linked glycosylation sites. 5, 33, 34 NA1 and NA2 alleles mediate quantitatively different capacity for phagocytosis despite equivalent ligand binding and density of receptor expression. 13 Of particular interest, there are two reports of patients with Fc␥RIIIB deficiency who developed SLE, 35, 36 although development of SLE is observed in only a small proportion of individuals deficient in Fc␥RIIIB. To our knowledge, the present study is the first to demonstrate significant association of Fc␥RIIIB polymorphism and SLE in a population-based association study.
Results from previous association studies on Fc␥Rs in various populations are listed in Table 6 . Although associations between the Fc␥RIIA, Fc␥RIIIA polymorphisms and SLE have been reported in several populations, this study indicated that SLE is associated with Fc␥RIIIB-NA1/2 polymorphism, but not with Fc␥RIIA and Fc␥RIIIA polymorphisms, in Japanese. It is possible to propose two interpretations for this discrepancy. Although the Fc␥R gene showing association with SLE varies among populations, alleles positively associated with SLE uniformly possess weak affinity for IgG. Therefore, it is possible that these Fc␥Rs possess similar contributions in terms of handling of IC, and the dosage of the 'weak-binding' alleles may primarily be associated with the susceptibility to SLE. If such a hypothesis is correct, the distribution of Fc␥RIIA and Fc␥RIIIA might reveal some difference between patients and healthy individuals when they are stratified according to Fc␥RIIIB genotypes. Although such difference was not observed in this study, further studies on a large number of subjects as well as on other populations are necessary.
Another possibility is that apparent association with Fc␥Rs may derive from linkage disequilibrium with other closely located gene(s) of primary significance. A number of candidate genes have been mapped within 1q21-24 region, including Fas ligand, IL-6 receptor, CD1, T cell receptor chain, and Fc␥RIIB. Further association studies focusing on the other candidate genes in this region need to be performed in various populations.
Since Fc␥RIIIB-NA2 allele is associated with Fc␥RIIIA-176F allele (Table 4 ) and the allele frequency of Fc␥RIIIB-NA2 among the Japanese control population is substantially lower compared with that of Fc␥RIIIA-176F allele (Table 1) , it is theoretically possible that the difference in the frequency of the NA2 allele reached statistical significance in the 2 analysis only because of the lower allele frequency among the control population. Therefore, the possibility that the Fc␥RIIIA-176F allele possesses the primary functional significance cannot be completely excluded at this point.
The present study also demonstrated that, among Fc␥RIIA, IIIA and IIIB genes, Fc␥RIIIA and IIIB are in significant linkage disequilibrium. The genomic organization of human Fc␥R family genes is not fully understood and seems to be complicated. It is considered that these genes have evolved through gene duplication and unequal crossing-over events. 3, 37 Information on the linkage disequilibrium among each Fc␥R family gene will provide a valuable tool for elucidating the evolutionary pathway and relative locations of these genes.
The case-control studies such as this are subject to problems of stratification, and therefore the conclusions should be interpreted with caution. It will be important to confirm both positive and negative observations in this study by independent case-control studies or familybased association studies.
In conclusion, significant association of Fc␥RIIIB polymorphism, but not of Fc␥RIIA and Fc␥RIIIA with SLE, was detected for the first time in this study. In addition, linkage disequilibrium was demonstrated between Fc␥RIIIA and Fc␥RIIIB. Further studies of Fc␥Rs as well as other candidate genes within 1q21-24 region in the Japanese and other populations will eventually reveal the actual susceptibility gene(s) within this region.
Patients and methods

Patients and healthy individuals
A total of 217 healthy individuals, 115 patients with RA and 81 patients with SLE were examined. All healthy individuals and patients were unrelated Japanese. Patients with RA consisted of 13 males and 102 females between ages 16 and 76 years (mean ± s.d. 58.6 ± 10.0). They were followed in the outpatient clinic of University of Tokyo Hospital or Fukuhara Hospital (Tokyo, Japan), and fulfilled the classification criteria of American College of Rheumatology. 38 One hundred and six patients suffered from RA with joint destruction and nine patients suffered from RA characterized by a non-erosive disease. Patients with SLE consisted of 12 males and 69 females between the ages 16 and 63 years (mean ± s.d. 40.3 ± 12.3). They were followed in the outpatient clinic of University of Tokyo Hospital or Matsuta Clinic (Tokyo), and fulfilled the classification criteria of American College of Rheumatology. 39 Healthy individuals, 124 males and 93 females between the ages of 21 and 60 years, consisted of the researchers, laboratory workers and students at the institutions where this study was carried out (mean ± s.d. 36.6 ± 9.9). It should be noted that the central part of Japan has been shown to be relatively homogeneous with respect to the genetic background, 40 permitting the case-control approach employed in this study.
The clinical characteristics of the patients were obtained by reviewing their medical records. When sufficient information was not available, such patients were excluded from the particular analysis. Nephritis (persistent proteinuria greater than 0.5 g/day or 3+, or presence of the cellular casts) and central nervous system disease (convulsion or psychosis) were defined according to ACR criteria. 39 This study was reviewed and approved by the Ethics Committee of the University of Tokyo, Graduate School of Medicine.
Genomic DNA
Genomic DNA from patients and healthy individuals was purified from peripheral blood leukocytes using the QIAamp blood kit (QIAGEN, Hilden, Germany).
Fc␥RIIA genotyping
The Fc␥RIIA-131H/R genotyping was performed using PCR-RFLP method with a mismatched primer. All Fc␥RIIA-specific primers were designed using previously reported nucleotide sequence (GenBank M90724). Two hundred and sixty base pair (260 bp) fragment from the Fc␥RIIA gene containing the polymorphic site was amplified using Fc␥RIIA-specific primers (2A-FF: 5′-CCAG GAGGGAGAAACCATCA-3′, 2A-FR: 5′-CTCTTCTCC CCTCCCTACAT-3′). The PCR reaction was performed in a Perkin-Elmer 9700 PCR system with 10 ng DNA, 5 pm of each primer, 0.25 mm dNTPs, 1.5 mm of MgCl 2 and 1.5 U of AmpliTaq Gold DNA polymerase (PerkinElmer, Norwalk, CT, USA) in a 25 l reaction volume. The annealing temperature was 60°C. Subsequently, the amplified fragment served as a template to amplify a 85 bp fragment in a nested PCR, using the second primer set (2A-SF: 5′-AAGGACAAGCCTCTGGTCAA-3′, 2A-SR: 5′-GGATGGAGAAGGTGGGATCCATA-3′). In this PCR, the forward primer (2A-SF) contained a mismatch that introduced a Nde I restriction site, only in the Fc␥RIIA-H131-derived fragment. The annealing temperature was 62°C. After the second PCR reaction the amplified products were digested with Nde I for 3 h and analyzed on a 10% polyacrylamide gel with SYBER Gold (Molecular Probes, Inc, OR, USA) staining.
The results of the PCR-RFLP were confirmed by PCR, using sequence specific primers (PCR-SSP). The H allelespecific forward primer (5′-AATCCCAGAAATTCT CCCA-3′) and R allele-specific forward primer (5′-AATCCCAGAAATTCTCCCG-3′) were used in combination with Fc␥RIIA-specific reverse primer (5′-TCTCAGACCTCCATGTAG-3′) to amplify 225 bp fragment in an allele-specific manner. Primers C4-L3 (5′-TGCGGATCCAGCAGTTTCGGAAG-3′) and C4-L4 (5′-ATAGGATCCTAAGGTCCCCTGGGCCT-3′) were included in all reactions and were used to amplify an internal positive control PCR product, 926 bp fragment from C4 gene. 41 PCR conditions were as follows: 96°C for 10 min, and then 30 cycles of: 96°C for 1 min, 52°C for 30 sec, 72°C for 1 min, and finally 72°C for 5 min. The amplified fragments were analyzed on a 10% polyacrylamide gel with SYBR Gold staining.
Fc␥RIIIA genotyping
The genotyping for Fc␥RIIIA-176F/V polymorphism was performed by PCR-SSCP. Fc␥RIIIA-specific primers (3A-F: 5′-TATTTACAGAATGGCAATGG-3′, 3A-R: 5′-GTGATGGTGATGTTCACAGT-3′) were designed to amplify a 152 bp fragment from the Fc␥RIIIA gene, containing the polymorphic site. 5 PCR was carried out using GeneAmp reagents and AmpliTaq Gold DNA poly-merase (Perkin-Elmer). The annealing temperature was 50°C.
The amplified DNA was analyzed using SSCP. The SSCP analysis was performed essentially according to the method described previously. 42 One l of solution containing the PCR product was mixed with 7 l of denaturing solution (95% formamide, 20 mm EDTA, 0.05% bromphenol blue, 0.05% xylene cyanol FF). The mixtures were denatured at 96°C for 5 min and immediately cooled on ice. One l of the mixtures was applied to 10% polyacrylamide gel (acrylamide:bis = 49:1) containing 5% glycerol. Electrophoresis was carried out for 90 min in 0.5 × TBE (45 mm Tris-borate [pH 8.0], 1 mm EDTA) at 4°C under constant current of 20 mA/gel, using a minigel electrophoresis apparatus with a constant temperature control system (90 × 80 × 1 mm, AE-6410 and AE-6370; ATTO, Tokyo, Japan). Single-strand DNA fragments in the gel were visualized by silver staining (Daiichi Pure Chemicals, Tokyo, Japan).
Direct sequencing was performed for 10 healthy individuals to determine the Fc␥RIIIA genotype of the samples which produced different SSCP patterns. PCR products were amplified and both sense and antisense strands were directly sequenced using the same primers as those for the SSCP analysis. Fluorescence-based automated cycle sequencing of PCR products was performed on ABI 377 using dye-terminator method according to the manufacturer's instruction (ABI PRISM™ dRhodamine Terminator Cycle Sequencing-Ready Reaction Kit).
Fc␥RIIIB genotyping
Fc␥RIIIB genotyping was carried out using PCR-preferential homoduplex formation assay (PCR-PHFA). The procedures will be described in detail elsewhere. 43 PHFA is an ELISA-based method for the detection of nucleotide substitutions within PCR amplicons, based on the strand competition during hybridization between double-labeled and unlabeled amplicons under the precisely controlled temperature gradient. 44 The primers NA-S (5′-TCTGAAGTGCCAGGGAG CCTACTCCCC-3′) and NA-A (5′-AGCTGCACCGGG TCACTGAGGGTG-3′) were used to amplify 174 bp fragment of Fc␥RIIIB containing the polymorphic sites. The annealing temperature was 71°C. Hybridization was performed in 30 l of 5 × SSC solution (0.3 m NaCl, 30 mm sodium citrate) containing 15 l of unlabeled sample amplicon and 1 l of labeled standard amplicon. In this condition, the molar ratio of standard DNA in the hybridization mixture to sample DNA was approximately 1:15. For the preferential formation of a homoduplex over a heteroduplex, the mixture was denatured at 98°C for 10 min, then cooled slowly to 90°C at the rate of 1°C per 10 min in a thermal cycler. Subsequently, 20 l of the mixture was transferred to a streptavidin-coated microtiter plate (Wakunaga, Hiroshima, Japan) containing 100 l of anti-dinitrophenyl (DNP) antibody conjugated with alkaline phosphatase (Wakunaga). After incubation, the wells were washed, and the double-labeled amplicons were detected using chromogenic substrate solution, as previously described. 44 When the unlabeled sample DNA amplicons possess the identical sequence as that of standard DNA amplicons double-labeled with biotin and DNP, the standard DNA is diluted and enzyme reaction becomes weak in the microtiter well. On the other hand, when sample DNA does not have the same sequence as that of standard DNA, no strand exchange occurs, resulting in strong enzyme reaction in the well.
Statistical analysis
The 2 test was used to compare the frequency of each Fc␥R genotype in patients and healthy individuals. Haplotype frequencies and linkage disequilibrium parameters were estimated from the typing results using the program developed for the 11th International Histocompatibility Workshop. 45 In brief, this method is based on the calculation of haplotype frequencies (HFs) which are most likely to explain the observed genotype data under the assumption of Hardy-Weinberg equilibrium. The linkage disequilibrium (LD) is the difference between the estimated haplotype frequency of AiBj, f(AiBj) and the product of the allele frequencies of Ai and Bj, f(Ai)f(Bj).
